genome-wide significant schizophrenia-associated variants occur within two miRNA loci -MIR137 and MIR548AJ2. These small, non-coding RNAs are potent regulators of translation, can target a wide variety of transcripts, and are therefore of particular interest in polygenic disorders such as schizophrenia. Methods: We obtained total RNA isolated from peripheral blood mononuclear cell (PBMC) samples from the Australian Schizophrenia Research Bank (ASRB). The samples included 36 individuals with schizophrenia and 15 healthy controls. We utilised small RNA and mRNA sequencing technology to examine both the miRNA and mRNA expression profiles of these sample. Raw reads were aligned to the human genome (hg38), annotated, counted and analysed for differential expression using an open source software pipeline. Correlations between miRNA and mRNA expression were found and matched to predicted TargetScan miRNA-mRNA interactions using the miRComb R package. Ingenuity Pathway Analysis and Gene Set Enrichment Analysis were performed to identify pathways and gene ontologies enriched for differentially expressed genes. Results: 35 miRNAs and 97 genes were differentially expressed (FDR<0.1); most miRNAs (21 out of 35) were downregulated, while the vast majority of mRNAs (80 out of 97) were upregulated. When males and females were analysed separately, we found 14 miRNAs and 365 genes differentially expressed in males, while females only showed 7 miRNAs and 1 gene (NRCAM -neuronal cell adhesion molecule) differentially expressed. Several miRNAs in males were found to significantly correlate with differentially expressed genes, including miR-1271-5p with schizophrenia candidate gene DGCR2. Furthermore, many differentially expressed genes and miRNAs have previously been linked to schizophrenia and neuronal function. Among males, several immune-and inflammation pathways were enriched for differentially expressed genes. Interestingly, while upregulated genes were enriched for immune-related gene ontologies, downregulated genes were enriched for gene ontologies relating to development. Discussion: These results contribute to a growing body of evidence that suggest peripheral miRNA and mRNA expression is altered in schizophrenia. We identify a general downregulation of miRNAs and upregulation of mRNAs in peripheral tissue in schizophrenia. Several significant correlations between miRNAs and mRNAs previously linked to schizophrenia and brain function suggest potential miRNA-mRNA interactions that may be significant for disease pathophysiology. 
S195. ELECTRORETINOGRAPHIC INDICES OF PHOTORECEPTOR, BIPOLAR, AND GANGLION
The retina is part of the CNS and provides a window into brain structure and function that has been useful in examining schizophrenia and other psychiatric disorders.
Methods:
In this ongoing study, we are using flash electroretinography (fERG) to compare retinal cell functioning in schizophrenia (n = 25) and major depressive disorder (MDD; n = 18, to date), both relative to psychiatrically healthy controls (n = 25). Data were averaged over both eyes and collected under both light-and dark-adapted conditions. The primary variables of interest were a-wave activity (reflecting photoreceptor response), b-wave activity (reflecting primarily bipolar cell activity), and photopic negative response (PhNR; reflecting ganglion cell activity).
Results: On light-adapted (photopic) tests, schizophrenia patients demonstrated significantly weaker cone and bipolar cell responses than the MDD and healthy control groups (ds = .76 to 1.25). On dark-adapted (scotopic) tests, all groups demonstrated a linear increase in photoreceptor and bipolar cell response with increases in stimulus intensity, but the rate of response gain per unit of intensity increase was significantly weaker for schizophrenia patients than for the other groups (ds = .84 to 1.11). Significant group differences were also found in PhNR amplitude, with the schizophrenia group demonstrating a weaker PhNR (measured at 72 ms post-stimulus presentation) as compared to the healthy control group (d = .50). In the MDD group, the minimum PhNR amplitude occurred significantly earlier than in either of the other two groups (ds =.80 to .92). Discussion: These data confirm abnormal retinal cell functioning in schizophrenia patients receiving treatment. Background: A number of studies have reported association between Toxoplasma gondii (T. gondii) and Chlamydia infection and the risk of schizophrenia. The aim of the present study was to compare the prevalence of T. gondii and Chlamydia infection between the schizophrenia and normal control subjects and to compare the clinical features between seropositive and seronegative Korean schizophrenia patients.
The rate of serum reactivity to T. gondii, Chlamydia trachomatis (C. trachomatis), Chlamydia pneumonia in 96 schizophrenia and 50 control subjects was investigated using enzyme-linked immunosorbent assay and indirect fluorescent antibody technique. The clinical symptoms of the schizophrenia patients were scored with Positive and Negative Syndrome Scale and a comparative analysis was carried out. Results: A significant positive association between immunoglobulin G (IgG) antibodies to T. gondii and C. trachomatis in schizophrenia was found, and the odds ratio of schizophrenia associated with IgG antibody was found to be 3.22 and 2.86, respectively. The Toxoplasma-seropositive schizophrenia patient had higher score on the negative subscale N1 and N7 and general psychopathology subscale G13, while C. trachomatis-seropositive schizophrenia patient had higher score on the general psychopathology subscale G10. Discussion: The results from the present study suggest significant association between T. gondii, C. trachomatis infection and schizophrenia. In future, further studies are needed to elucidate the correlation between the two types of infection and schizophrenia. WCST assesses perseverative responses and failure to maintain set, and the Stroop assesses time in seconds for completing the Inhibition and Switching conditions. The cognitive measures were combined with data from the Norwegian Birth Registry (NMBR). Information on OC was collected from the NMBR containing information about all births in Norway, including information about maternal health before and during pregnancy, and any complications arising during pregnancy or birth. The registry includes information about medication during pregnancy, labor interventions, birth complications, maternal complications after birth, whether this was a live birth, any diagnoses in the child or evidence of congenital abnormalities. Results: Group differences in OC were studied with Student's t-tests and Chi-square tests. The association between OC and cognitive function were studied using linear regression analyses. The results indicated no group differences in OC in EOS and healthy controls. However, a shorter gestational length in the EOS group led to significant decreases in the overall neurocognitive composite score (MCCB), in processing speed and in the two executive function tasks. Discussion: Our findings indicate that a shorter gestational length did not increase the risk for developing EOS, but was significantly associated with the cognitive difficulties in this group. In particular, executive functioning were affected, a finding in line with those of Brown et al (2009) , showing that prenatal infections were associated with impaired executive function. Interestingly, reductions in neurocognitive performance among those exposed to OC was less extensive in the healthy control group with the same labor-conditions, which may indicate a greater effect of OC on neuropsychological development in schizophrenia. In conclusion, gestational length does not increase the risk for developing EOS, but significantly affects the cognitive difficulties -particularly executive function -seen among cases. Background: Schizophrenia is a highly heritable disease, mediated through a combination of common and rare genetic variants. In addition to genetic risk, several putative environmental risk factors have been studied in the context of schizophrenia. It has been suggested that the genetic effects on the etiology of schizophrenia may be of limited explanatory power if not viewed in the context of interaction with environmental stressors. Here, in a pre-adolescent population-based sample, we used polygenic risk scores from a case-control discovery sample of the Psychiatric Genomics Consortium as indicators of genetic vulnerability to schizophrenia. In addition, hair cortisol levels were obtained as a naturalistic quantitative metric of long-term physiological stress. We examined whether cortisol levels moderated the relationship between schizophrenia polygenic risks scores and pre-adolescent brain structure. Methods: This study was embedded in the Generation R Study, a prospective birth cohort from the Netherlands. Polygenic risk scores for schizophrenia were calculated in children of European ancestry only. P-value thresholds for inclusion of genetic variants in the polygenic risk score varied between P < 0.001 and P < 1. Hair cortisol was collected when the children were approximately 6 years old. At age 9 years, children underwent a magnetic resonance imaging (MRI) procedure to assess volumetric brain measures. After genetic and neuroimaging quality control procedures, the final sample consisted of 522 participants. Linear regression models were conducted to examine the associations between schizophrenia polygenic risk scores, hair cortisol levels, and brain volumes. All analyses were adjusted for age, sex, hair color, hair product use and four genetic principal components. Results: Schizophrenia polygenic risk scores were not associated with hair cortisol levels (P-value threshold [PT] < 0.001, β = -0.03, 95% confidence interval [CI] -0.11 -0.05, P = 0.441), cortical grey matter volume (PT < 0.001, β = -0.03, 95% CI -0.11 -0.05, P = 0.457) or cerebral white matter volume (PT < 0.001, β = -0.04, 95% CI -0.12 -0.04, P = 0.356). Higher schizophrenia polygenic risk scores were associated with lower total ventricle volume (PT <0.001, β = -0.10, 95% CI -0.19 --0.02, P = 0.022), including when mutually adjusted for total brain volume. Notably however, hair cortisol exhibited a positive interaction with schizophrenia risk scores in predicting total ventricle volume (PT < 0.001, β = 0.10, 95% CI 0.01 -0.18, P = 0.027), i.e. higher schizophrenia polygenic risk score and higher hair cortisol levels were associated with increased ventricle volumes. Hair cortisol was not independently associated with total ventricle volume (PT < 0.001, β = -0.05, 95% CI -0.14 -0.03, P = 0.215). Discussion: Elevated hair cortisol levels, a biological index of long-term stress, moderated the association between genetic vulnerability to schizophrenia and total cerebral ventricle volume among pre-adolescents. These findings underscore the importance of the interplay between genes and environment in shaping brain development. Using a polygenic risk score for schizophrenia, we provide novel, albeit preliminary, evidence for geneenvironment interaction between genetic risk for schizophrenia and environmental stressors in the general pre-adolescent population. This may help to elucidate underlying etiologies and possible early interventions for the psychosis spectrum. 
S199. ENHANCED OLFACTORY IDENTIFICATION IN ADOLESCENTS WITH PSYCHOTIC EXPERIENCES
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Background: The olfactory system has a widely distributed anatomical network reaching both cortical and subcortical structures (Milardi et al., 2017) . Olfactory dysfunction has been associated with schizophrenia (Moberg & Turetsky, 2003) , where deficits in odour identification (Seidman et al., 1997) , odor detection threshold sensitivity (Serby et al., 1990 ) and odour memory (Wu et al., 1993) can be seen early in the course of the disorder
